☆ 4.6 Article

Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination

VIRUSES-BASEL (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

Leo Swadling et al.

Summary: Research suggests that some individuals can clear potential SARS-CoV-2 infection after exposure, with T cells playing a role in the process. Studying healthcare workers who tested negative for antibodies revealed that they had stronger and more diverse memory T cells, with a focus on RTC.

NATURE (2022)

Add to Collection

Article Microbiology

Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity

Alejandro Vallejo et al.

Summary: SARS-CoV-2 spike mRNA vaccines not only induce specific responses to the spike protein, but also enhance T-cell responses to the membrane and nucleocapsid proteins. This suggests that mRNA vaccines serve as broad boosters of cellular responses and provide extended protection against viral variants.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Immunology

Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2

Jose L. Casado et al.

Summary: Little is known about the factors associated with the lack of T-cell response to mRNA vaccines against SARS-CoV-2. A study on a cohort of 61 healthcare workers found that 21% and 16% showed a lack of CD4+ and CD8+ T-cell response after the first dose of the mRNA BNT162b vaccine, and 12% and 7% showed a lack of response after the second dose, respectively. Pre-existing T-cell immunity, either from past infection or cross-reactive cellular response, was significantly associated with T-cell response frequency and magnitude. Baseline CD4+ T-cell levels correlated positively with the titer of specific IgG antibodies. These findings suggest that cross-reactive T-cells are linked to better cellular and humoral responses after mRNA vaccination.

VACCINE: X (2022)

Add to Collection

Article Immunology

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde et al.

Summary: SARS-CoV-2-specific T cell epitopes were identified in convalescent and unexposed individuals, showing cross-reactivity with common cold coronaviruses. The diversity of SARS-CoV-2 T cell responses may be associated with mild symptoms of COVID-19.

NATURE IMMUNOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Recent endemic coronavirus infection is associated with less-severe COVID-19

Manish Sagar et al.

Summary: The study suggests that individuals with prior endemic coronavirus infections were tested more frequently for respiratory infections, but had similar rates of acquiring SARS-CoV-2. Additionally, patients with previous endemic coronavirus infections experienced less severe cases of COVID-19.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Aurelien Sokal et al.

Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.

CELL (2021)

Add to Collection

Article Infectious Diseases

SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study

Jose L. Casado et al.

Summary: A pre-existing T-cell response against SARS-CoV-2 does not appear to reduce the risk of incident infections, but may contribute to asymptomatic or mild disease, rapid viral clearance, and differences in seroconversion.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Letter Infectious Diseases

SARS-CoV-2 antibodies and utility of point of care testing in Health Care Workers from a spanish University Hospital in Madrid

Mario Rodriguez-Dominguez et al.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Immunology

Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Jose L. Casado et al.

Summary: The study found differences in the duration of T-cell and humoral immune responses among healthcare workers infected with COVID-19, with significantly lower T-cell response in those who lost antibodies early. Over time, most cases experienced a decline in antibodies, and a portion of cases lost T-cell response.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals after mRNA vaccination

Rishi R. Goel et al.

Summary: mRNA vaccines exhibit robust serological and cellular priming, with naïve individuals requiring two doses for optimal antibody responses, especially against the B.1.351 variant. Memory B cells specific for spike protein and RBD were efficiently primed by vaccination, while recovered individuals showed significant boosting after the first dose, correlating with preexisting memory B cell levels. Identifying distinct responses based on prior SARS-CoV-2 exposure suggests that recovered subjects may only need one vaccine dose for peak responses, which can inform vaccine distribution strategies in resource-limited settings.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses

F. Javier Ibarrondo et al.

Summary: Studies on two SARS-CoV-2 mRNA vaccines have shown that they provide about 95% protection from symptomatic infection in the short term, but questions remain about the comparison and stability of vaccine-induced antibody levels to natural infection. Antibody levels decline similarly after vaccination and natural infection, indicating potential need for booster shots.

ACS NANO (2021)

Add to Collection

Article Multidisciplinary Sciences

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

Valerie Oberhardt et al.

Summary: After vaccination, CD8(+) T cells become important effector cells in providing early protection, being effectively mobilized one week after primary vaccination and maintaining stability after booster vaccination. Compared with natural infection, vaccine-induced CD8(+) T cells exhibit similar functional capacities but with a different subset distribution.

NATURE (2021)

Add to Collection

Article Immunology

CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients

Vamsee Mallajosyula et al.

Summary: The study suggests that CD8(+) T cells with conserved specificities are more abundant in COVID-19 patients with mild disease, indicating a potential protective role.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Immunology

T-cell response after first dose of BNT162b2 SARS-CoV-2 vaccine among healthcare workers with previous infection or cross-reactive immunity

Jose L. Casado et al.

Summary: This study found that COVID-19 convalescents had greater antibody response and T-cell immunity after receiving the first dose of BNT162b2 vaccine compared to infection-naive individuals, with those having pre-existing T-cell immunity showing nearly all T-cell responses post-vaccination.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Alba Grifoni et al.

CELL (2020)

Add to Collection

Article Cell Biology

Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner

Federica Sotgia et al.

AGING-US (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Julian Braun et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Jose Mateus et al.

SCIENCE (2020)

Add to Collection

Article Microbiology

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

Carolin Loos et al.

MSPHERE (2020)

Add to Collection

Article Immunology

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

Catherine J. Reynolds et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Immunology

The early cellular signatures of protective immunity induced by live viral vaccination

Siegfried Kohler et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2012)

Add to Collection

Article Biochemistry & Molecular Biology

A structural analysis of M protein in coronavirus assembly and morphology

Benjamin W. Neuman et al.

JOURNAL OF STRUCTURAL BIOLOGY (2011)

Add to Collection

Article Immunology

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

Geoffrey J. Gorse et al.

CLINICAL AND VACCINE IMMUNOLOGY (2010)

Add to Collection

Article Immunology

Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a US Metropolitan Population

Emily G. Severance et al.

CLINICAL AND VACCINE IMMUNOLOGY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.